nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—Methyltestosterone—Prednisone—systemic scleroderma	0.00353	1	CbGdCrCtD
Moxifloxacin—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000309	0.00031	CcSEcCtD
Moxifloxacin—Myocardial infarction—Prednisone—systemic scleroderma	0.000309	0.00031	CcSEcCtD
Moxifloxacin—Breast disorder—Methotrexate—systemic scleroderma	0.000309	0.00031	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000308	0.000309	CcSEcCtD
Moxifloxacin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000308	0.000309	CcSEcCtD
Moxifloxacin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000308	0.000309	CcSEcCtD
Moxifloxacin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000307	0.000308	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000307	0.000308	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000307	0.000308	CcSEcCtD
Moxifloxacin—Insomnia—Lisinopril—systemic scleroderma	0.000306	0.000307	CcSEcCtD
Moxifloxacin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000305	0.000307	CcSEcCtD
Moxifloxacin—Paraesthesia—Lisinopril—systemic scleroderma	0.000304	0.000305	CcSEcCtD
Moxifloxacin—Vomiting—Captopril—systemic scleroderma	0.000304	0.000305	CcSEcCtD
Moxifloxacin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000302	0.000303	CcSEcCtD
Moxifloxacin—Dyspnoea—Lisinopril—systemic scleroderma	0.000302	0.000303	CcSEcCtD
Moxifloxacin—Rash—Captopril—systemic scleroderma	0.000301	0.000302	CcSEcCtD
Moxifloxacin—Dermatitis—Captopril—systemic scleroderma	0.000301	0.000302	CcSEcCtD
Moxifloxacin—Somnolence—Lisinopril—systemic scleroderma	0.000301	0.000302	CcSEcCtD
Moxifloxacin—Headache—Captopril—systemic scleroderma	0.000299	0.0003	CcSEcCtD
Moxifloxacin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000299	0.0003	CcSEcCtD
Moxifloxacin—Dyspepsia—Lisinopril—systemic scleroderma	0.000298	0.000299	CcSEcCtD
Moxifloxacin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000297	0.000298	CcSEcCtD
Moxifloxacin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000297	0.000298	CcSEcCtD
Moxifloxacin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000296	0.000297	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000296	0.000297	CcSEcCtD
Moxifloxacin—Asthma—Methotrexate—systemic scleroderma	0.000295	0.000296	CcSEcCtD
Moxifloxacin—Decreased appetite—Lisinopril—systemic scleroderma	0.000294	0.000295	CcSEcCtD
Moxifloxacin—Eosinophilia—Methotrexate—systemic scleroderma	0.000292	0.000293	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000292	0.000293	CcSEcCtD
Moxifloxacin—Fatigue—Lisinopril—systemic scleroderma	0.000292	0.000293	CcSEcCtD
Moxifloxacin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000292	0.000293	CcSEcCtD
Moxifloxacin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000291	0.000292	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00029	0.000291	CcSEcCtD
Moxifloxacin—Hypersensitivity—Leflunomide—systemic scleroderma	0.00029	0.000291	CcSEcCtD
Moxifloxacin—Pancreatitis—Methotrexate—systemic scleroderma	0.000289	0.00029	CcSEcCtD
Moxifloxacin—Pain—Lisinopril—systemic scleroderma	0.000289	0.00029	CcSEcCtD
Moxifloxacin—Constipation—Lisinopril—systemic scleroderma	0.000289	0.00029	CcSEcCtD
Moxifloxacin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000289	0.00029	CcSEcCtD
Moxifloxacin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000288	0.000289	CcSEcCtD
Moxifloxacin—Bradycardia—Prednisone—systemic scleroderma	0.000288	0.000289	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000286	0.000287	CcSEcCtD
Moxifloxacin—Diarrhoea—Azathioprine—systemic scleroderma	0.000285	0.000286	CcSEcCtD
Moxifloxacin—Haemoglobin—Prednisone—systemic scleroderma	0.000284	0.000285	CcSEcCtD
Moxifloxacin—Nausea—Captopril—systemic scleroderma	0.000284	0.000285	CcSEcCtD
Moxifloxacin—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000283	0.000284	CcSEcCtD
Moxifloxacin—Haemorrhage—Prednisone—systemic scleroderma	0.000283	0.000284	CcSEcCtD
Moxifloxacin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000282	0.000283	CcSEcCtD
Moxifloxacin—Asthenia—Leflunomide—systemic scleroderma	0.000282	0.000283	CcSEcCtD
Moxifloxacin—Hallucination—Prednisone—systemic scleroderma	0.000281	0.000282	CcSEcCtD
Moxifloxacin—Pancytopenia—Methotrexate—systemic scleroderma	0.00028	0.000281	CcSEcCtD
Moxifloxacin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000279	0.00028	CcSEcCtD
Moxifloxacin—Pruritus—Leflunomide—systemic scleroderma	0.000278	0.000279	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Prednisone—systemic scleroderma	0.000278	0.000279	CcSEcCtD
Moxifloxacin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000277	0.000278	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000277	0.000278	CcSEcCtD
Moxifloxacin—Neutropenia—Methotrexate—systemic scleroderma	0.000276	0.000277	CcSEcCtD
Moxifloxacin—Dysuria—Methotrexate—systemic scleroderma	0.000276	0.000277	CcSEcCtD
Moxifloxacin—Dizziness—Azathioprine—systemic scleroderma	0.000276	0.000277	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00027	0.000271	CcSEcCtD
Moxifloxacin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000269	0.00027	CcSEcCtD
Moxifloxacin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000269	0.00027	CcSEcCtD
Moxifloxacin—Diarrhoea—Leflunomide—systemic scleroderma	0.000269	0.00027	CcSEcCtD
Moxifloxacin—Urticaria—Lisinopril—systemic scleroderma	0.000269	0.00027	CcSEcCtD
Moxifloxacin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000268	0.000269	CcSEcCtD
Moxifloxacin—Abdominal pain—Lisinopril—systemic scleroderma	0.000267	0.000268	CcSEcCtD
Moxifloxacin—Body temperature increased—Lisinopril—systemic scleroderma	0.000267	0.000268	CcSEcCtD
Moxifloxacin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000266	0.000267	CcSEcCtD
Moxifloxacin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000266	0.000267	CcSEcCtD
Moxifloxacin—Vomiting—Azathioprine—systemic scleroderma	0.000265	0.000266	CcSEcCtD
Moxifloxacin—Pneumonia—Methotrexate—systemic scleroderma	0.000265	0.000266	CcSEcCtD
Moxifloxacin—Eye disorder—Prednisone—systemic scleroderma	0.000264	0.000265	CcSEcCtD
Moxifloxacin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000264	0.000265	CcSEcCtD
Moxifloxacin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000263	0.000264	CcSEcCtD
Moxifloxacin—Infestation—Methotrexate—systemic scleroderma	0.000263	0.000264	CcSEcCtD
Moxifloxacin—Infestation NOS—Methotrexate—systemic scleroderma	0.000263	0.000264	CcSEcCtD
Moxifloxacin—Rash—Azathioprine—systemic scleroderma	0.000263	0.000264	CcSEcCtD
Moxifloxacin—Dermatitis—Azathioprine—systemic scleroderma	0.000263	0.000263	CcSEcCtD
Moxifloxacin—Depression—Methotrexate—systemic scleroderma	0.000262	0.000263	CcSEcCtD
Moxifloxacin—Headache—Azathioprine—systemic scleroderma	0.000261	0.000262	CcSEcCtD
Moxifloxacin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000261	0.000262	CcSEcCtD
Moxifloxacin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000262	CcSEcCtD
Moxifloxacin—Dizziness—Leflunomide—systemic scleroderma	0.00026	0.000261	CcSEcCtD
Moxifloxacin—Renal failure—Methotrexate—systemic scleroderma	0.000259	0.00026	CcSEcCtD
Moxifloxacin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000258	0.000259	CcSEcCtD
Moxifloxacin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000257	0.000258	CcSEcCtD
Moxifloxacin—Stomatitis—Methotrexate—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Moxifloxacin—Angiopathy—Prednisone—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Moxifloxacin—Conjunctivitis—Methotrexate—systemic scleroderma	0.000256	0.000257	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000256	0.000257	CcSEcCtD
Moxifloxacin—Immune system disorder—Prednisone—systemic scleroderma	0.000255	0.000256	CcSEcCtD
Moxifloxacin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000253	0.000254	CcSEcCtD
Moxifloxacin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000253	0.000254	CcSEcCtD
Moxifloxacin—Arrhythmia—Prednisone—systemic scleroderma	0.000253	0.000253	CcSEcCtD
Moxifloxacin—Sweating—Methotrexate—systemic scleroderma	0.000252	0.000253	CcSEcCtD
Moxifloxacin—Haematuria—Methotrexate—systemic scleroderma	0.000251	0.000252	CcSEcCtD
Moxifloxacin—Vomiting—Leflunomide—systemic scleroderma	0.00025	0.000251	CcSEcCtD
Moxifloxacin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000249	0.00025	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000249	0.00025	CcSEcCtD
Moxifloxacin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000248	0.000249	CcSEcCtD
Moxifloxacin—Epistaxis—Methotrexate—systemic scleroderma	0.000248	0.000249	CcSEcCtD
Moxifloxacin—Rash—Leflunomide—systemic scleroderma	0.000248	0.000249	CcSEcCtD
Moxifloxacin—Dermatitis—Leflunomide—systemic scleroderma	0.000248	0.000249	CcSEcCtD
Moxifloxacin—Mental disorder—Prednisone—systemic scleroderma	0.000248	0.000249	CcSEcCtD
Moxifloxacin—Nausea—Azathioprine—systemic scleroderma	0.000248	0.000248	CcSEcCtD
Moxifloxacin—Headache—Leflunomide—systemic scleroderma	0.000247	0.000247	CcSEcCtD
Moxifloxacin—Malnutrition—Prednisone—systemic scleroderma	0.000246	0.000247	CcSEcCtD
Moxifloxacin—Erythema—Prednisone—systemic scleroderma	0.000246	0.000247	CcSEcCtD
Moxifloxacin—Agranulocytosis—Methotrexate—systemic scleroderma	0.000246	0.000247	CcSEcCtD
Moxifloxacin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000244	0.000245	CcSEcCtD
Moxifloxacin—Asthenia—Lisinopril—systemic scleroderma	0.000243	0.000244	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000243	CcSEcCtD
Moxifloxacin—Pruritus—Lisinopril—systemic scleroderma	0.000239	0.00024	CcSEcCtD
Moxifloxacin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000239	0.00024	CcSEcCtD
Moxifloxacin—Haemoglobin—Methotrexate—systemic scleroderma	0.000237	0.000238	CcSEcCtD
Moxifloxacin—Rash—Mycophenolic acid—systemic scleroderma	0.000237	0.000238	CcSEcCtD
Moxifloxacin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000237	0.000237	CcSEcCtD
Moxifloxacin—Haemorrhage—Methotrexate—systemic scleroderma	0.000236	0.000237	CcSEcCtD
Moxifloxacin—Hepatitis—Methotrexate—systemic scleroderma	0.000236	0.000237	CcSEcCtD
Moxifloxacin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000235	0.000236	CcSEcCtD
Moxifloxacin—Headache—Mycophenolic acid—systemic scleroderma	0.000235	0.000236	CcSEcCtD
Moxifloxacin—Pharyngitis—Methotrexate—systemic scleroderma	0.000235	0.000235	CcSEcCtD
Moxifloxacin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000234	0.000235	CcSEcCtD
Moxifloxacin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000234	0.000235	CcSEcCtD
Moxifloxacin—Nausea—Leflunomide—systemic scleroderma	0.000234	0.000235	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000233	0.000234	CcSEcCtD
Moxifloxacin—Vision blurred—Prednisone—systemic scleroderma	0.000232	0.000233	CcSEcCtD
Moxifloxacin—Urethral disorder—Methotrexate—systemic scleroderma	0.000232	0.000232	CcSEcCtD
Moxifloxacin—Diarrhoea—Lisinopril—systemic scleroderma	0.000231	0.000232	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000228	0.000229	CcSEcCtD
Moxifloxacin—Visual impairment—Methotrexate—systemic scleroderma	0.000228	0.000229	CcSEcCtD
Moxifloxacin—Anaemia—Prednisone—systemic scleroderma	0.000227	0.000228	CcSEcCtD
Moxifloxacin—Agitation—Prednisone—systemic scleroderma	0.000226	0.000227	CcSEcCtD
Moxifloxacin—Angioedema—Prednisone—systemic scleroderma	0.000225	0.000226	CcSEcCtD
Moxifloxacin—Dizziness—Lisinopril—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Moxifloxacin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000223	0.000224	CcSEcCtD
Moxifloxacin—Nausea—Mycophenolic acid—systemic scleroderma	0.000223	0.000224	CcSEcCtD
Moxifloxacin—Malaise—Prednisone—systemic scleroderma	0.000222	0.000223	CcSEcCtD
Moxifloxacin—Vertigo—Prednisone—systemic scleroderma	0.000221	0.000222	CcSEcCtD
Moxifloxacin—Eye disorder—Methotrexate—systemic scleroderma	0.000221	0.000222	CcSEcCtD
Moxifloxacin—Syncope—Prednisone—systemic scleroderma	0.000221	0.000222	CcSEcCtD
Moxifloxacin—Tinnitus—Methotrexate—systemic scleroderma	0.00022	0.000221	CcSEcCtD
Moxifloxacin—Cardiac disorder—Methotrexate—systemic scleroderma	0.000219	0.00022	CcSEcCtD
Moxifloxacin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000218	0.000219	CcSEcCtD
Moxifloxacin—Loss of consciousness—Prednisone—systemic scleroderma	0.000216	0.000217	CcSEcCtD
Moxifloxacin—Vomiting—Lisinopril—systemic scleroderma	0.000215	0.000216	CcSEcCtD
Moxifloxacin—Angiopathy—Methotrexate—systemic scleroderma	0.000214	0.000215	CcSEcCtD
Moxifloxacin—Immune system disorder—Methotrexate—systemic scleroderma	0.000213	0.000214	CcSEcCtD
Moxifloxacin—Rash—Lisinopril—systemic scleroderma	0.000213	0.000214	CcSEcCtD
Moxifloxacin—Convulsion—Prednisone—systemic scleroderma	0.000213	0.000214	CcSEcCtD
Moxifloxacin—Dermatitis—Lisinopril—systemic scleroderma	0.000213	0.000214	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000213	0.000214	CcSEcCtD
Moxifloxacin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000213	CcSEcCtD
Moxifloxacin—Hypertension—Prednisone—systemic scleroderma	0.000212	0.000213	CcSEcCtD
Moxifloxacin—Chills—Methotrexate—systemic scleroderma	0.000212	0.000213	CcSEcCtD
Moxifloxacin—Headache—Lisinopril—systemic scleroderma	0.000212	0.000213	CcSEcCtD
Moxifloxacin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00021	0.00021	CcSEcCtD
Moxifloxacin—Arthralgia—Prednisone—systemic scleroderma	0.00021	0.00021	CcSEcCtD
Moxifloxacin—Myalgia—Prednisone—systemic scleroderma	0.00021	0.00021	CcSEcCtD
Moxifloxacin—Anxiety—Prednisone—systemic scleroderma	0.000209	0.00021	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000208	0.000209	CcSEcCtD
Moxifloxacin—Discomfort—Prednisone—systemic scleroderma	0.000207	0.000208	CcSEcCtD
Moxifloxacin—Mental disorder—Methotrexate—systemic scleroderma	0.000207	0.000208	CcSEcCtD
Moxifloxacin—Malnutrition—Methotrexate—systemic scleroderma	0.000206	0.000206	CcSEcCtD
Moxifloxacin—Erythema—Methotrexate—systemic scleroderma	0.000206	0.000206	CcSEcCtD
Moxifloxacin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000203	0.000203	CcSEcCtD
Moxifloxacin—Dysgeusia—Methotrexate—systemic scleroderma	0.000201	0.000202	CcSEcCtD
Moxifloxacin—Nausea—Lisinopril—systemic scleroderma	0.000201	0.000202	CcSEcCtD
Moxifloxacin—Oedema—Prednisone—systemic scleroderma	0.000201	0.000202	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000201	0.000202	CcSEcCtD
Moxifloxacin—Back pain—Methotrexate—systemic scleroderma	0.000199	0.0002	CcSEcCtD
Moxifloxacin—Shock—Prednisone—systemic scleroderma	0.000198	0.000198	CcSEcCtD
Moxifloxacin—Nervous system disorder—Prednisone—systemic scleroderma	0.000197	0.000198	CcSEcCtD
Moxifloxacin—Tachycardia—Prednisone—systemic scleroderma	0.000196	0.000197	CcSEcCtD
Moxifloxacin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000197	CcSEcCtD
Moxifloxacin—Skin disorder—Prednisone—systemic scleroderma	0.000195	0.000196	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000194	0.000195	CcSEcCtD
Moxifloxacin—Vision blurred—Methotrexate—systemic scleroderma	0.000194	0.000195	CcSEcCtD
Moxifloxacin—Anorexia—Prednisone—systemic scleroderma	0.000191	0.000192	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000191	0.000192	CcSEcCtD
Moxifloxacin—Anaemia—Methotrexate—systemic scleroderma	0.00019	0.000191	CcSEcCtD
Moxifloxacin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000188	0.000189	CcSEcCtD
Moxifloxacin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000187	0.000188	CcSEcCtD
Moxifloxacin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000187	0.000187	CcSEcCtD
Moxifloxacin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000186	0.000186	CcSEcCtD
Moxifloxacin—Malaise—Methotrexate—systemic scleroderma	0.000185	0.000186	CcSEcCtD
Moxifloxacin—Vertigo—Methotrexate—systemic scleroderma	0.000185	0.000185	CcSEcCtD
Moxifloxacin—Leukopenia—Methotrexate—systemic scleroderma	0.000184	0.000185	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000183	0.000184	CcSEcCtD
Moxifloxacin—Insomnia—Prednisone—systemic scleroderma	0.000182	0.000182	CcSEcCtD
Moxifloxacin—Paraesthesia—Prednisone—systemic scleroderma	0.00018	0.000181	CcSEcCtD
Moxifloxacin—Cough—Methotrexate—systemic scleroderma	0.000179	0.00018	CcSEcCtD
Moxifloxacin—Convulsion—Methotrexate—systemic scleroderma	0.000178	0.000179	CcSEcCtD
Moxifloxacin—Dyspepsia—Prednisone—systemic scleroderma	0.000177	0.000177	CcSEcCtD
Moxifloxacin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000176	0.000177	CcSEcCtD
Moxifloxacin—Myalgia—Methotrexate—systemic scleroderma	0.000175	0.000176	CcSEcCtD
Moxifloxacin—Arthralgia—Methotrexate—systemic scleroderma	0.000175	0.000176	CcSEcCtD
Moxifloxacin—Chest pain—Methotrexate—systemic scleroderma	0.000175	0.000176	CcSEcCtD
Moxifloxacin—Decreased appetite—Prednisone—systemic scleroderma	0.000175	0.000175	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000174	0.000175	CcSEcCtD
Moxifloxacin—Fatigue—Prednisone—systemic scleroderma	0.000173	0.000174	CcSEcCtD
Moxifloxacin—Discomfort—Methotrexate—systemic scleroderma	0.000173	0.000174	CcSEcCtD
Moxifloxacin—Constipation—Prednisone—systemic scleroderma	0.000172	0.000172	CcSEcCtD
Moxifloxacin—Confusional state—Methotrexate—systemic scleroderma	0.000169	0.00017	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000168	0.000168	CcSEcCtD
Moxifloxacin—Feeling abnormal—Prednisone—systemic scleroderma	0.000166	0.000166	CcSEcCtD
Moxifloxacin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000165	0.000165	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000164	0.000165	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000164	0.000165	CcSEcCtD
Moxifloxacin—Skin disorder—Methotrexate—systemic scleroderma	0.000163	0.000164	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000162	0.000163	CcSEcCtD
Moxifloxacin—Anorexia—Methotrexate—systemic scleroderma	0.00016	0.000161	CcSEcCtD
Moxifloxacin—Urticaria—Prednisone—systemic scleroderma	0.00016	0.00016	CcSEcCtD
Moxifloxacin—Body temperature increased—Prednisone—systemic scleroderma	0.000159	0.000159	CcSEcCtD
Moxifloxacin—Abdominal pain—Prednisone—systemic scleroderma	0.000159	0.000159	CcSEcCtD
Moxifloxacin—Hypotension—Methotrexate—systemic scleroderma	0.000157	0.000157	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000153	0.000153	CcSEcCtD
Moxifloxacin—Insomnia—Methotrexate—systemic scleroderma	0.000152	0.000152	CcSEcCtD
Moxifloxacin—Paraesthesia—Methotrexate—systemic scleroderma	0.000151	0.000151	CcSEcCtD
Moxifloxacin—Dyspnoea—Methotrexate—systemic scleroderma	0.00015	0.00015	CcSEcCtD
Moxifloxacin—Somnolence—Methotrexate—systemic scleroderma	0.000149	0.00015	CcSEcCtD
Moxifloxacin—Hypersensitivity—Prednisone—systemic scleroderma	0.000148	0.000149	CcSEcCtD
Moxifloxacin—Dyspepsia—Methotrexate—systemic scleroderma	0.000148	0.000148	CcSEcCtD
Moxifloxacin—Decreased appetite—Methotrexate—systemic scleroderma	0.000146	0.000146	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000145	0.000145	CcSEcCtD
Moxifloxacin—Fatigue—Methotrexate—systemic scleroderma	0.000145	0.000145	CcSEcCtD
Moxifloxacin—Asthenia—Prednisone—systemic scleroderma	0.000144	0.000145	CcSEcCtD
Moxifloxacin—Pain—Methotrexate—systemic scleroderma	0.000144	0.000144	CcSEcCtD
Moxifloxacin—Pruritus—Prednisone—systemic scleroderma	0.000142	0.000143	CcSEcCtD
Moxifloxacin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000138	0.000139	CcSEcCtD
Moxifloxacin—Diarrhoea—Prednisone—systemic scleroderma	0.000137	0.000138	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000137	0.000138	CcSEcCtD
Moxifloxacin—Urticaria—Methotrexate—systemic scleroderma	0.000133	0.000134	CcSEcCtD
Moxifloxacin—Dizziness—Prednisone—systemic scleroderma	0.000133	0.000133	CcSEcCtD
Moxifloxacin—Body temperature increased—Methotrexate—systemic scleroderma	0.000133	0.000133	CcSEcCtD
Moxifloxacin—Abdominal pain—Methotrexate—systemic scleroderma	0.000133	0.000133	CcSEcCtD
Moxifloxacin—Vomiting—Prednisone—systemic scleroderma	0.000128	0.000128	CcSEcCtD
Moxifloxacin—Rash—Prednisone—systemic scleroderma	0.000127	0.000127	CcSEcCtD
Moxifloxacin—Dermatitis—Prednisone—systemic scleroderma	0.000127	0.000127	CcSEcCtD
Moxifloxacin—Headache—Prednisone—systemic scleroderma	0.000126	0.000126	CcSEcCtD
Moxifloxacin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000124	0.000124	CcSEcCtD
Moxifloxacin—Asthenia—Methotrexate—systemic scleroderma	0.00012	0.000121	CcSEcCtD
Moxifloxacin—Nausea—Prednisone—systemic scleroderma	0.000119	0.00012	CcSEcCtD
Moxifloxacin—Pruritus—Methotrexate—systemic scleroderma	0.000119	0.000119	CcSEcCtD
Moxifloxacin—Diarrhoea—Methotrexate—systemic scleroderma	0.000115	0.000115	CcSEcCtD
Moxifloxacin—Dizziness—Methotrexate—systemic scleroderma	0.000111	0.000111	CcSEcCtD
Moxifloxacin—Vomiting—Methotrexate—systemic scleroderma	0.000107	0.000107	CcSEcCtD
Moxifloxacin—Rash—Methotrexate—systemic scleroderma	0.000106	0.000106	CcSEcCtD
Moxifloxacin—Dermatitis—Methotrexate—systemic scleroderma	0.000106	0.000106	CcSEcCtD
Moxifloxacin—Headache—Methotrexate—systemic scleroderma	0.000105	0.000106	CcSEcCtD
Moxifloxacin—Nausea—Methotrexate—systemic scleroderma	9.97e-05	0.0001	CcSEcCtD
